BOSTON — In this Healio video exclusive, Juan P. Frias, MD, discusses his presentation on newer treatment options for type 2 diabetes at the Cardiometabolic Health Congress.
Frias, medical director and principal investigator at Velocity Clinical Research in Los Angeles, said that “over the last 2 decades, the philosophy of the management of type 2 diabetes has changed.”
Development of drugs such as SGLT2 inhibitors and GLP-1 receptor agonists has led to moving from a “glucose-centric approach to one where we’re clearly concerned about improving glycemic